TNGX Tango Therapeutics, Inc.
P/E
--
Forward P/E
-15.525585
Price/Sales
79.211876
Beta
1.152
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Farallon Capital Discloses New $190M Stake in Tango Therapeutics
In a quarterly disclosure with the SEC, Farallon Capital Management revealed it established a new position in Tango Therapeutics (TNGX) by purchasing 9.10...
Perceptive Advisors Boosts TNGX Stake by Over 300%
Perceptive Advisors, a major life sciences investment firm, significantly increased its stake in Tango Therapeutics (TNGX) during the second quarter of 2026....